In this study, we describe the synthesis and characterization of silver nanoparticles (Ag-NPs) of different sizes and evaluated their antibacterial activity. Particles size and morphology were characterized by transmission electron microscopy. Evaluation of the bacteriostatic effects was performed by ultraviolet–visible spectrophotometry and comet assays. The smaller the particle size of Ag-NPs, the smaller the value of the minimum inhibitory concentration (MIC) and minimum bactericidal concentrations (MBC), indicating the greater the antibacterial activity. The antibacterial activity was determined by the generation of reactive oxygen species (ROS) by bacteria and by bacterial membrane damage. In this study, we determined ROS-induced damage of bacteria caused by Ag-NPs. In conclusion, our findings indicated that Ag-NPs were effective at different particle sizes and concentrations and that the smaller the particle size of Ag-NPs, the greater the antibacterial activity.
The increasing burden and health risks of antimicrobial resistance (AMR) pose a great threat to society overall. Lipopeptides exhibit great potential as novel and safe alternatives to traditional antibiotics. In this study, the strain YA215, which was isolated from the mangrove area in Beibu Gulf, Guangxi, China, was identified as Bacillus velezensis. Then, YA215 lipopeptide extracts (YA215LE) from B. velezensis was found to exhibit a wide spectrum of antibacterial and antifungal activities. Additionally, YA215LE was identified and found to contain three groups of lipopeptides (surfactin, iturin, and fengycin). Furthermore, one separation fraction (BVYA1) with significant antibacterial activity was obtained. Additionally, liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis of BVYA1 showed three molecular ion peaks ([M + H]+: m/z 980.62; 994.66; 1008.66) corresponding to conventional surfactin homologs. By MS/MS analysis, BVYA1 was identified as sufactin with the precise amino acid sequence Glu–Leu/Ile–Leu–Val–Asp–Leu–Leu/Ile and hydroxyl fatty acids with 11–13 carbons. [M + H]+ at m/z 980.62 was detected for the first time in B. velezensis, which demonstrates that the strain corresponds to a new surfactin variant. In particular, BVYA1 showed antibacterial activity with the minimum inhibitory concentration (MIC) values of 7.5–15 μg/ml. Finally, the preliminary mechanism of inhibiting E. coli treated with BVYA1 showed that BVYA1 effectively permeabilized the cytoplasmic membrane and disrupted the morphology of targeted bacterial cells. In conclusion, this study suggests that the YA215LE from B. velezensis YA215 might be a potential candidate for a bactericide.
1 January 2010 in Chemical and Pharmaceutical Bulletin
To improve bioavailability of poorly water-soluble YH439, a thermal reversible microemulsion system was prepared using modified fatty acids such as capric acid and palmitic acid with PEG 400. A combination of Capric-PEG 400 and Palmitic-PEG 400 with a ratio of 1 : 3 used as a lipid matrix and Cremophor RH40 and Neobee M-5® were selected as an oil and a surfactant, respectively. The microemulsion with melting point of 36.5 °C was produced by mixing the lipid matrices, Cremophor RH40® and Neobee M-5® with a volume ratio of 5 : 4 : 1. After the microemulsion was dispersed in the aqueous medium, the average particle size of 28 nm was obtained. At the release measurements of YH439 after 45 min suspension in pH 1.2 aqueous medium, about 80%, 65%, 10% and less than 5% of drug were released from the thermal reversible microemulson, Gelucire® formulation, 5% Ca-carboxymethylcellulose (CMC) suspension and YH439 powder, respectively. The apparent permeability of YH439 in microemulsion either from apical to basolateral or basolateral to apical after measuring YH439 across a Caco-2 cell monolayer in a Transwell® larger than Gelucire® formulation or 5% Na-CMC suspension. The area under the drug concentration–time curves (AUC) and maximal blood concentration (Cmax) after oral administration of YH439 loaded on thermal reversible microemulsion were significantly increased than drug loaded on either Gelucire formulation or 5% Na-CMC suspension. Thus, the present work demonstrates that the thermal reversible microemulsion system of YH439 greatly enhances the bioavailability of YH439 after oral administration due to the improvement of solubility and dispersion of the drug in the artificial gastrointestinal tract without pepsin.
Cutting fluid is a type of fluid used in the metal-cutting process. It is prone to microbial growth during use, which can lead to the deterioration of its various useful properties; however, the mechanism underlying this deterioration remains unclear. This study analyzed the microbial diversity of field-sampled cutting fluids, and those with higher levels of diversity were used to inoculate other fluid samples in order to further study the effects of microbial growth on the properties of cutting fluids. The results show that the surface of cutting fluid sampled from the tank of a machining tool tank contained predominantly aerobic bacteria, while the bottom mainly harbored anaerobic and facultative microorganisms, with Yarrowia lipolytica representing the dominant fungus. Some obligate anaerobic bacteria were also present in the cutting fluid. Organic acids secreted by anaerobic microbial activity reduced the pH of the cutting fluid, as well as its resistance to corrosion. The metabolic activity of the aerobic microorganisms also consumed certain key components of the cutting fluid, which ultimately further lowered its pH and resistance to corrosion. Moreover, the number of fungi increased significantly during the later stages of the experiment. The rolling and bridging action of the resulting fungal mycelium caused flocculation of the effective components in the cutting fluid, resulting in reduced lubricity and poor stability. This study provides a theoretical basis for developing more effective measures to inhibit microbial growth and delay the deterioration of cutting fluid, thereby helping to improve the technical quality of the metal-cutting industry.
9 February 2026 in International Journal of Biological Macromolecules